# Protalix BioTherapeutics, Inc.: Form DEF 14A, filed Sep 1, 2017

- Company: [Protalix BioTherapeutics, Inc.](/companies/plx.md) (CIK 1006281)
- Form: DEF 14A
- Filed: 2017-09-01
- Accepted by EDGAR: Sep 1, 2017, 16:04 ET
- Period: 2017-10-19
- Accession: 0001144204-17-046387
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1006281/000114420417046387/v474379_def14a.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1006281/000114420417046387/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1006281/000114420417046387/v474379_def14a.htm

Filed Sep 1, 2017.
Source: SEC EDGAR, the filing index for accession 0001144204-17-046387. Last ingested by Listed: Nov 10, 2026, 16:48 ET. No prices; not investment advice.
